- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT02367339
Assessment of the Prevalence of Extended-Spectrum Betalactamase Producing Enterobacteriaceae Among ICU Staff (REASSE)
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
Prospective epidemiological study with voluntary non-medical staff member (i.e. nurses and nursing assistants) and medical staff in two French ICUs.
Assessment of self-reported risk factors for MDR-bacteria colonization. Self-performed rectal swab with isolation of ESBL-producting Enterobacteriaceae, identification of bacterial species and antibiotic suspectibilities.
Characterization of Escherichia coli ESBL.
Study Type
Enrollment (Anticipated)
Contacts and Locations
Study Locations
-
-
-
Clermont-Ferrand, France, 63003
- Recruiting
- CHU de Clermont-Ferrand
-
Principal Investigator:
- Julien PASCAL
-
Sub-Investigator:
- Bertrand SOUWEINE
-
Sub-Investigator:
- Jean-Michel CONSTANTIN
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Sampling Method
Study Population
Description
Inclusion Criteria:
- volunteers
Exclusion Criteria:
-
Study Plan
How is the study designed?
Design Details
- Time Perspectives: Prospective
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Digestive tract colonization by ESBL
Time Frame: at day 1
|
Digestive tract colonization by ESBL-producing Enterobacteriaceae on 1 faeces sample
|
at day 1
|
Collaborators and Investigators
Investigators
- Principal Investigator: Julien PASCAL, University Hospital, Clermont-Ferrand
Study record dates
Study Major Dates
Study Start
Primary Completion (Anticipated)
Study Completion (Anticipated)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Estimate)
Study Record Updates
Last Update Posted (Estimate)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- CHU-0224
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
product manufactured in and exported from the U.S.
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Antibiotic Resistance
-
Nantes University HospitalCompleted
-
University Hospital, AkershusOslo University Hospital; Helse Stavanger HF; Sorlandet Hospital HF; Sykehuset... and other collaboratorsTerminatedAntibiotic Drug Resistance
-
Uppsala UniversityKarolinska University Hospital; Sahlgrenska University Hospital, Sweden; University... and other collaboratorsRecruiting
-
University of British ColumbiaRecruiting
-
University of British ColumbiaTerminated
-
University of California, San FranciscoRecruitingAntibiotic Resistance | Ocular Surface Microbiome | Gut ResistomeUnited States
-
University of Southern DenmarkCompleted
-
Kufa UniversityCompleted
-
University of OxfordLondon School of Hygiene and Tropical Medicine; University College, London; KEMRI-Wellcome... and other collaboratorsUnknownAntibiotic Resistance | Malnutrition Severe | Antibiotic ToxicityKenya, Uganda
-
Cairo UniversityNot yet recruitingPeriodontitis | Antibiotic Resistance | Antibiotic Use
Clinical Trials on ESBL
-
University Hospital, Basel, SwitzerlandRecruiting
-
Centre Hospitalier Universitaire de BesanconUniversity Hospital, Geneva; UMC Utrecht; University of Oxford; University Hospital... and other collaboratorsCompletedEnterobacteriaceae Infections | Resistance BacterialFrance
-
University of BordeauxUnknownCritical Illness | Microbial Colonization | Extended Spectrum Beta-Lactamase Producing Bacteria InfectionFrance
-
José Raimundo Araujo de AzevedoNot yet recruiting
-
Jian-cang Zhou M.D.CompletedCommunity Acquired InfectionChina
-
University Hospital, AngersUnknownESBL-producing Enterobacteriaceae Infections
-
Fondation Hôpital Saint-JosephRecruiting
-
Maria J.G.T. VehreschildTerminated
-
Tan Tock Seng HospitalMayo ClinicUnknownSepsis | Fungemia | Bacteremia | Blood Stream InfectionSingapore
-
Wyeth is now a wholly owned subsidiary of PfizerCompletedKlebsiella Infections | Escherichia Coli InfectionsKorea, Republic of